16 results

Posted on 27.08.2024
A vision for Europe’s medtech future: Safeguarding Europe’s access to medtech and innovation
The EU medical technology regulations need a rethink to boost competitiveness that better safeguards patient access to innovation Europe has a strong and diverse medical technology sector and some of the best health services in the world. However, a serious crisis is on the horizon, which threatens our shared progress. We must address this challenge […]

Posted on 10.01.2023
How AI shapes healthcare’s ‘now’ and ‘then’
As a Lead of AI4Health at AI4Belgium (Belgium’s federal ecosystem for AI), holder of the Chair of Artificial Intelligence and Digital Medicine at the University of Mons and a Medical Doctor at the Brugmann University Hospital in Brussels, AI solutions have profoundly changed my work in healthcare. AI can impact the day-to-day of healthcare professionals […]

Posted on 14.07.2022
Addressing new expectations for the future of health
The past few years have seen a seismic shift in the entire healthcare landscape. The COVID-19 crisis required a new level of “always-on” and “right now” innovation to enable care to be delivered to the front lines, to all patients, and across geographies. As COVID-19 evolves from an acute crisis to a chronic issue with unpredictable ebbs and flows, the hyper-focused approach to innovation is more important than ever. The world now knows what we can do, even when conditions are less than optimal. Our focus on helping patients by getting the best evidence, tools, and support to clinicians demonstrated the power of collaboration, imagination and dedication. Moving forward, patients and healthcare partners will accept nothing less than that level of commitment to transform the future of health forever.

Posted on 01.07.2022
Putting medical technologies at the heart of health innovation in Europe
From robotic surgery and wearables to connected devices and AI-powered diagnostics, medical technologies are reinventing healthcare. Europe’s medtech sector is making unprecedented investments in research & innovation – and joining the Innovative Healthcare Initiative for the first time. I sense that something big is happening in healthcare research. A tectonic shift in Europe’s health innovation […]

Posted on 19.11.2021
EU move on mergers threatens innovation
At first sight, EU policy on mergers and acquisitions might not need to concern patients and frontline healthcare workers too much. However, a subtle shift in the rules on whether two companies can agree to become one could have a profound impact on access to medical innovation. To understand why this might be, it’s important […]

Posted on 23.06.2021
MedTech: a partner in building a research-oriented, innovative, and resilient Europe
The medical technology sector welcomes the European Commission’s 3rd edition of the EU Research and Innovation Days (R&I Days). This event could not have come at a more important time, as this year marks the official launch of Horizon Europe, the EU’s most ambitious research and innovation program to date. The response to the Covid-19 […]

Posted on 17.03.2021
MedTech Slovenia: building the future together
The next chapter in the story of Slovenia’s medical technology industry has begun – and it is being co-written by leaders from the in-vitro diagnostics and medical devices sectors. SIEDMA and SLO-MED have formally merged to become MedTech Slovenia. Together, we are combining our expertise to speak for our diverse industry with one voice. […]

Posted on 10.12.2020
Accelerating medtech innovation in paediatrics
For start-ups working in paediatrics, competitions can offer funding, exposure and invaluable access to mentorship. Despite advances in medical technology, the fruits of progress are not shared equally across age groups. One of the biggest challenges we see in the paediatric domain, and especially among those younger in the age spectrum, is the lack […]

Posted on 22.05.2020
Closing the innovation loop: how start-ups can show value
One of my great frustrations is to see start-ups fall at the final hurdle. Too many early-stage companies with promising innovations spend their energy – and funds – answering crucial questions about the safety and effectiveness of their products, only to find that they have no answers to the additional questions asked by payers. […]